Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Safety of biweekly α1-antitrypsin treatment in the RAPID programme

T. Greulich, J. Chlumsky, M. Wencker, O. Vit, M. Fries, T. Chung, A. Shebl, C. Vogelmeier, KR. Chapman, NG. McElvaney, RAPID Trial Group,

. 2018 ; 52 (5) : . [pub] 20181129

Language English Country England, Great Britain

Document type Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19035011

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035011
003      
CZ-PrNML
005      
20191017101412.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1183/13993003.00897-2018 $2 doi
035    __
$a (PubMed)30237305
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Greulich, Timm $u Dept of Medicine, Respiratory and Critical Care Medicine, Philipps-University Marburg, Member of the German Center for Lung Diseases (DZL), Marburg, Germany.
245    10
$a Safety of biweekly α1-antitrypsin treatment in the RAPID programme / $c T. Greulich, J. Chlumsky, M. Wencker, O. Vit, M. Fries, T. Chung, A. Shebl, C. Vogelmeier, KR. Chapman, NG. McElvaney, RAPID Trial Group,
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a intravenózní infuze $7 D007262
650    _2
$a plíce $x patofyziologie $7 D008168
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a plicní emfyzém $x farmakoterapie $x etiologie $x patofyziologie $7 D011656
650    _2
$a výsledek terapie $7 D016896
650    _2
$a alfa-1-antitrypsin $x aplikace a dávkování $x škodlivé účinky $7 D000515
650    _2
$a deficit alfa1-antitrypsinu $x komplikace $x farmakoterapie $x patofyziologie $7 D019896
655    _2
$a dopisy $7 D016422
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chlumsky, Jan $u Dept of Pulmonary Diseases, Charles University, Prague, Czech Republic.
700    1_
$a Wencker, Marion $u conresp, Loerzweiler, Germany.
700    1_
$a Vit, Oliver $u Clinical Research and Development, CSL Behring, Bern, Switzerland.
700    1_
$a Fries, Michael $u Clinical Strategy and Development, CSL Behring, King of Prussia, PA, USA.
700    1_
$a Chung, Thomas $u Statistics Dept, CSL Behring, King of Prussia, PA, USA.
700    1_
$a Shebl, Amgad $u Global Clinical Safety and Pharmacovigilance, CSL Behring, Marburg, Germany.
700    1_
$a Vogelmeier, Claus $u Dept of Medicine, Respiratory and Critical Care Medicine, Philipps-University Marburg, Member of the German Center for Lung Diseases (DZL), Marburg, Germany.
700    1_
$a Chapman, Kenneth R $u Dept of Medicine, University of Toronto, Toronto, ON, Canada.
700    1_
$a McElvaney, Noel G $u Irish Centre for Genetic Lung disease, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland. A list of the RAPID Trial Group members can be found in the study group information at the end of this article.
710    2_
$a RAPID Trial Group
773    0_
$w MED00001660 $t The European respiratory journal $x 1399-3003 $g Roč. 52, č. 5 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30237305 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191017101840 $b ABA008
999    __
$a ok $b bmc $g 1451671 $s 1073561
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 52 $c 5 $e 20181129 $i 1399-3003 $m The European respiratory journal $n Eur Respir J $x MED00001660
LZP    __
$a Pubmed-20191007
Back

Find record

Citation metrics

Archiving options